通達創智(001368.SZ):目前公司健康護理領域的口腔護理及消毒盒業務正常開展
格隆匯12月20日丨通達創智(001368.SZ)在投資者互動平台表示,目前公司健康護理領域的口腔護理及消毒盒業務正常開展,具體業績情況請關注公司的定期報吿。公司持續看好健康護理領域的廣闊市場空間和發展機遇,公司業務部門正在進一步開發和培養健康護理領域的客户;同時,公司將繼續強化“產品設計+智能製造”體系建設,不斷開拓更多健康護理領域的產品品類,持續為客户提供高性價比的全球一站式柔性交付。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.